Tompkins Financial Corp Reduces Stock Holdings in The Procter & Gamble Company (NYSE:PG)

Tompkins Financial Corp reduced its position in The Procter & Gamble Company (NYSE:PG) by 1.6% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 50,223 shares of the company’s stock after selling 832 shares during the quarter. Tompkins Financial Corp’s holdings in Procter & Gamble were worth $8,699,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors also recently added to or reduced their stakes in the company. Concurrent Investment Advisors LLC grew its holdings in Procter & Gamble by 4.5% during the 3rd quarter. Concurrent Investment Advisors LLC now owns 94,109 shares of the company’s stock valued at $16,300,000 after buying an additional 4,035 shares in the last quarter. Radnor Capital Management LLC purchased a new stake in Procter & Gamble in the 3rd quarter worth approximately $5,705,000. Welch Group LLC boosted its holdings in Procter & Gamble by 0.9% in the 3rd quarter. Welch Group LLC now owns 323,870 shares of the company’s stock valued at $56,094,000 after purchasing an additional 2,990 shares during the period. GAMMA Investing LLC grew its position in shares of Procter & Gamble by 67.2% during the 2nd quarter. GAMMA Investing LLC now owns 26,803 shares of the company’s stock valued at $4,420,000 after purchasing an additional 10,777 shares in the last quarter. Finally, Quintet Private Bank Europe S.A. raised its position in shares of Procter & Gamble by 15.0% in the third quarter. Quintet Private Bank Europe S.A. now owns 426,820 shares of the company’s stock worth $73,925,000 after buying an additional 55,620 shares in the last quarter. Hedge funds and other institutional investors own 65.77% of the company’s stock.

Insider Buying and Selling

In other news, insider Balaji Purushothaman sold 12,800 shares of the business’s stock in a transaction dated Thursday, October 24th. The stock was sold at an average price of $168.99, for a total value of $2,163,072.00. Following the transaction, the insider now directly owns 11,566 shares in the company, valued at $1,954,538.34. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In related news, insider Balaji Purushothaman sold 12,800 shares of the company’s stock in a transaction on Thursday, October 24th. The shares were sold at an average price of $168.99, for a total transaction of $2,163,072.00. Following the completion of the transaction, the insider now owns 11,566 shares in the company, valued at approximately $1,954,538.34. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Jon R. Moeller sold 31,797 shares of the stock in a transaction dated Tuesday, August 20th. The shares were sold at an average price of $169.22, for a total transaction of $5,380,688.34. Following the transaction, the chief executive officer now directly owns 300,777 shares of the company’s stock, valued at $50,897,483.94. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 313,597 shares of company stock valued at $53,268,499. 0.18% of the stock is owned by corporate insiders.

Procter & Gamble Stock Performance

Shares of NYSE:PG traded up $4.30 during midday trading on Friday, reaching $167.71. 7,506,566 shares of the company’s stock traded hands, compared to its average volume of 6,666,331. The Procter & Gamble Company has a one year low of $142.50 and a one year high of $177.94. The stock has a 50 day moving average of $171.08 and a 200 day moving average of $168.15. The company has a market cap of $394.96 billion, a price-to-earnings ratio of 28.92, a P/E/G ratio of 3.48 and a beta of 0.42. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.55 and a current ratio of 0.75.

Procter & Gamble (NYSE:PG) last released its quarterly earnings results on Friday, October 18th. The company reported $1.93 earnings per share for the quarter, beating the consensus estimate of $1.90 by $0.03. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The firm had revenue of $21.74 billion for the quarter, compared to analysts’ expectations of $21.99 billion. During the same period in the prior year, the firm earned $1.83 EPS. The company’s revenue was down .6% compared to the same quarter last year. As a group, equities research analysts anticipate that The Procter & Gamble Company will post 6.94 EPS for the current fiscal year.

Procter & Gamble Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be given a dividend of $1.0065 per share. The ex-dividend date is Friday, October 18th. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.40%. Procter & Gamble’s payout ratio is currently 69.31%.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on the company. StockNews.com lowered Procter & Gamble from a “buy” rating to a “hold” rating in a research note on Thursday, August 1st. Evercore ISI upped their price objective on shares of Procter & Gamble from $180.00 to $183.00 and gave the stock an “outperform” rating in a research report on Monday, October 21st. DZ Bank upgraded shares of Procter & Gamble from a “hold” rating to a “buy” rating and set a $190.00 target price for the company in a research report on Thursday, August 29th. Dbs Bank lowered shares of Procter & Gamble from a “strong-buy” rating to a “hold” rating in a research report on Thursday, August 1st. Finally, Morgan Stanley upped their price objective on Procter & Gamble from $174.00 to $191.00 and gave the stock an “overweight” rating in a report on Monday, October 21st. Nine research analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, Procter & Gamble has a consensus rating of “Moderate Buy” and a consensus price target of $177.00.

Procter & Gamble Profile

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.